NCT04425850View on ClinicalTrials.gov

USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19

CompletedOBSERVATIONAL
Enrollment

229

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

August 10, 2020

Study Completion Date

August 10, 2020

Conditions
Covid19
Interventions
COMBINATION_PRODUCT

Iota carrageenan nasal spray and Ivermectin oral drops (used as buccal drops)

Topical application in the nose and oral cavity

Trial Locations (1)

1802

Hospital Eurnekian, Buenos Aires

All Listed Sponsors
lead

Eurnekian Public Hospital

OTHER

NCT04425850 - USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 | Biotech Hunter | Biotech Hunter